Abstract: A nose and throat anti-influenza solution is described that decreases the likelihood influenza infection and its spread. The solution's components are readily available and have been used to treat humans for other ailments previously, leading to an easily implemented, scalable, safe, and cost-effective solution. The core components of the solution include: specially denatured alcohol (SDA); Triton x-100; sodium saccharin; 1,8 cineole (eucalyptol); thymol; methyl salicylate; menthol; sorbitol and/or glycerin; sodium benzoate; poloxamer 407; polysorbate 80; and distilled water. Optionally, the solution also includes one or more of the following: citric acid; sambucus nigra agglutinin; a lectin that binds 2,3 sialic acid; nonoxynol-9; sialyllactose; a protease; a protease inhibitor; and/or chloroquine. The solution is applied to the nasal cavity via a pre-moistened cotton swab or a pre-moistened facial tissue and the solution is applied to the back of the throat via a spray, gum, or gargle solution.

Abstract: An interface mechanism is provided that removably unites a carbon dioxide absorption canister with a patient breathing circuit on a ventilator. The interface mechanism includes a cradle that is moveably positioned between a first position and a second position, wherein in the first position, the canister is coupled to the cradle and the cradle is positioned such that the canister is in fluid communication with the breathing circuit. In the second position, the canister is removable from the cradle and the cradle extends at an angle from the patient breathing circuit. The interface mechanism advantageously provides visual indication when the canister is removed and the breathing circuit is operating as a closed loop system, without CO2 filtration. The mechanism also facilitates efficient and accurate fluid connection between the carbon dioxide absorption canister and the breathing circuit.